Parag Doctor of Keynote Capital said there could be a technical bounce in Wockhardt towards the Rs 1500 level.

Wockhardt can see 15% EPS cut, may slide further: CIMB

Prakash Agarwal of CIMB expects a 12-15 percent kind of earnings per share (EPS) draw for Wockhardt; there could be future downsides apart from existing facilities.

Like L&T over SBI; cautious on Ranbaxy, Wockhardt: PN Vijay

Portfolio Manager, PN Vijay is bullish on L&T despite the stock falling heavily on Thursday. He is bullish on the real estate sector. Also, he suggests buying pharma stock Wockhardt, on dips.

Sell Wockhardt around Rs 1620-1630: Kulkarni

Shardul Kulkarni of Angel Broking is of the view that, one should should wait for some bit of a bounce in Wockhardt and can sell the stock around Rs 1620-1630.

Invest in Wockhardt, says Sukhani

Sudarshan Sukhani of s2analytics.com advises to invest in Wockhardt.

Buy Wockhardt around Rs 1650: SP Tulsian

According to SP Tulsian of sptulsian.com one can buy Wockhardt around Rs 1650.

Re-rating story will continue in Wockhardt: Pathiparampil

Bino Pathiparampil of IIFL believes the re-rating story will continue in Wockhardt. He expects some good returns going forward.

Buy Wockhardt, says Sukhani

Sudarshan Sukhani of s2analytics.com advises to buy Wockhardt at current levels.

Enter Wockhardt around Rs 1500: Sukhani

Sudarshan Sukhani of s2analytics.com advises to enter Wockhardt around Rs 1500.

Buy Wockhardt on decline: Sekhar

Phani Sekhar, Fund Manager, Angel Broking is of the view that one can buy Wockhardt on decline.

Buy Wockhardt: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Wockhardt.

Hold Wockhardt, says Ashu Madan

According to Ashu Madan, President of core client group at Religare Securities, one should continue to hold Wockhardt. He expects the stock to outperform rest of the market.

SP Tulsian upbeat on Glenmark Pharma, Wockhardt

SP Tulsian of sptulsian.com is upbeat on Glenmark Pharma, Wockhardt and Lupin.

Wockhardt can touch Rs 2200: Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that Wockhardt can touch Rs 2200.

Sell Yes Bank, JSW Steel: Doctor

In CNBC-TV18's popular show Bull's Eye, Parag Doctor, Keynote Capital shares trading strategy of the day.

Bull's eye: Buy Shriram Transport, Wockhardt; short HDIL

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Wockhardt has target of Rs 2400: SP Tulsian

Wockhardt has target of Rs 2400, says SP Tulsian, sptulsian.com.

Book partial profit in Wockhardt, says Sukhani

Sudarshan Sukhani, s2analytics.com advises investors to book partial profit in Wockhardt.

Sell Wockhardt around Rs 1850: SP Tulsian

SP Tulsian, sptulsian.com advises traders to sell Wockhardt around Rs 1850.

Wockhardt can touch Rs 1800: Sukhani

Wockhardt can touch Rs 1800, says Sudarshan Sukhani of s2analytics.com.

Buy Wockhardt, says Sukhani

Sudarshan Sukhani of s2analytics.com advises traders to buy Wockhardt at current levels.

Positive on OnMobile and metal stocks: Tulsian

SP Tulsian of sptulsian.com, says that after the change in management of OnMobile and considering the financials he is positive on the stock. He is also positive on select metal stocks.

Hold Wockhardt, United Spirits: SP Tulsian

SP Tulsian, sptulsian.com advises traders to hold Wockhardt and United Spirits in their portfolio.

Fantastic 4: Stocks that can fetch good returns in a week

In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his views on stocks across various sectors. He picked four multibagger stocks for the week ahead. He suggested going long on Pantaloon, Century Textiles, Tata Global and Wockhardt.

Tater bullish on Punjab and Sind, Aurobindo Pharma

In an interview to CNBC-TV18, Aashish Tater, Head of Research at Fortunewizard.com recommends Punjab and Sind Bank and Aurobindo Pharma as multibagger stocks.